These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 4318945)

  • 41. Selection of L cell sublines resistant to (E)-5-(2-bromovinyl)-2'-deoxyuridine.
    Shiraki K; Vonka V; De Clercq E; Rapp F
    Intervirology; 1991; 32(4):228-33. PubMed ID: 1650764
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monoclonal antibodies to herpes simplex virus thymidine kinase.
    Banks LM; Vaughan PJ; Meredith D; Powell KL
    J Gen Virol; 1984 Sep; 65 ( Pt 9)():1625-30. PubMed ID: 6088685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Possible peptide chain termination mutants in thymide kinase gene of a mammalian virus, herpes simplex virus.
    Summers WP; Wagner M; Summers WC
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4081-4. PubMed ID: 172894
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative study of the transformation of various thymidine kinase-deficient human and animal cell lines with the thymidine kinase gene of the Herpes simplex virus].
    Grinenko NF; Al'tshteĭn AL
    Genetika; 1987 Apr; 23(4):670-6. PubMed ID: 3034725
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Herpes simplex virus as a source of thymidine kinase for thymidine kinase-deficient mouse cells: suppression and reactivation of the viral enzyme.
    Davidson RL; Adelstein SJ; Oxman MN
    Proc Natl Acad Sci U S A; 1973 Jul; 70(7):1912-6. PubMed ID: 4352962
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus.
    Tenser RB; Miller RL; Rapp F
    Science; 1979 Aug; 205(4409):915-7. PubMed ID: 224454
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of herpes simplex virus type 1 thymidine kinase in the presence of thymidine analogues.
    Zucker ML; Mancini WR; Otto MJ; Lee JJ; Prusoff WH
    Antiviral Res; 1986 Mar; 6(2):69-81. PubMed ID: 3010857
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Viral thymidine kinase-based transfection systems.
    Kit S
    Prog Clin Biol Res; 1983; 132C():327-36. PubMed ID: 6314358
    [No Abstract]   [Full Text] [Related]  

  • 49. Incorporation of the herpes simplex virus thymidine-kinase gene into a mammalian cell line using fragments of the virus genome.
    Darby G; Minson AC; Wildy P
    IARC Sci Publ (1971); 1978; (24 Pt 1):489-93. PubMed ID: 221352
    [No Abstract]   [Full Text] [Related]  

  • 50. Role of the herpes simplex virus 1 internal repeat sequences in pathogenicity.
    Jenkins FJ; Martin JR
    Intervirology; 1990; 31(2-4):129-38. PubMed ID: 2165040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transient expression of deletion mutants of the herpes simplex virus thymidine kinase-encoding gene in mouse fibroblast cells.
    Zemskova MY; Fodor I
    Gene; 1991 Oct; 106(2):249-53. PubMed ID: 1657725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Replication of HSV-1 in murine peritoneal macrophages: comparison of various virus strains with different properties.
    Görtz J; Brake B; Härle-Grupp V; Falke D
    Arch Virol; 1984; 79(3-4):173-87. PubMed ID: 6320776
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential metabolism of (E)-5-(2-bromovinyl)-2'-deoxyuridine in wild-type and drug-resistant herpes simplex virus-infected cells.
    Ayisi N; Wall R; De Clercq E; Sacks S
    Antiviral Res; 1985; Suppl 1():45-9. PubMed ID: 3002265
    [No Abstract]   [Full Text] [Related]  

  • 54. Trigeminal ganglion infection by thymidine kinase-negative mutants of herpes simplex virus after in vivo complementation.
    Tenser RB; Edris WA
    J Virol; 1987 Jul; 61(7):2171-4. PubMed ID: 3035217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory effects of (E)-5-(2-bromovinyl)-2'-deoxyuridine (BVDU) and related compounds on herpes simplex virus (HSV)-infected cells and HSV thymidine kinase gene-transformed cells.
    Balzarini J; De Clercq E
    Methods Find Exp Clin Pharmacol; 1989 Jun; 11(6):379-89. PubMed ID: 2545982
    [No Abstract]   [Full Text] [Related]  

  • 56. Acyclovir resistance in a patient with chronic mucocutaneous herpes simplex infection.
    Westheim AI; Tenser RB; Marks JG
    J Am Acad Dermatol; 1987 Nov; 17(5 Pt 2):875-80. PubMed ID: 2824577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Virus specified enzyme activity and RNA species in herpes simplex virus type 1 transformed mouse cells.
    Jamieson AT; Macnab JC; Perbal B; Clements JB
    J Gen Virol; 1976 Sep; 32(3):493-508. PubMed ID: 184243
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ABORTIVE INFECTION OF CANINE CELLS BY HERPES SIMPLEX VIRUS. I. CHARACTERIZATION OF VIRAL PROGENY FROM CO-OPERATIVE INFECTION WITH MUTANTS DIFFERING IN CAPACITY TO MULTIPLY IN CANINE CELLS.
    ROIZMAN B; AURELIAN L
    J Mol Biol; 1965 Mar; 11():528-38. PubMed ID: 14267274
    [No Abstract]   [Full Text] [Related]  

  • 59. Resistance of hamster cells transformed by herpes simplex virus type 2 to superinfection by herpes simplex viruses.
    Doller E; Duff R; Rapp F
    Intervirology; 1973; 1(3):154-67. PubMed ID: 4359758
    [No Abstract]   [Full Text] [Related]  

  • 60. Regulation of the herpes simplex virus gene for thymidine kinase in clonal derivatives of transformed mouse L-cells.
    Buttyan R; Spear PG
    IARC Sci Publ (1971); 1978; (24 Pt 1):517-22. PubMed ID: 221356
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.